New Wosulin 30/70 Injection
Marketer
Wockhardt Ltd
Salt Composition
Insulin Isophane (70%) + Human insulin (30%)
Overview New Wosulin 30/70 Injection
Wosulin 30/70 Injection combines two insulin types—intermediate and rapid-acting—to manage blood glucose in adults and children with type 1 and type 2 diabetes. This dual-insulin therapy helps regulate blood sugar, typically used alongside other diabetes medications as directed by a healthcare professional. Proper subcutaneous injection technique will be demonstrated. Administer 15 minutes before or within 20 minutes after meal initiation. Discontinue only under medical supervision. Effective diabetes management includes this medication, alongside a balanced diet, consistent exercise, and weight management as recommended. Regular blood glucose monitoring and result reporting are crucial for dose adjustment. Hypoglycemia (low blood sugar) is a common side effect; proper dosing, regular meals, and glucose monitoring mitigate this risk. Excessive alcohol consumption also increases this risk. Injection site reactions (redness, swelling) may occur. Weight gain is possible. Other potential side effects include rash, edema, or itching. Avoid use with hypoglycemia. Prior kidney, liver, or heart conditions should be disclosed. Pregnant or breastfeeding individuals require physician consultation for appropriate dosage adjustments.
Uses of New Wosulin 30/70 Injection
Managing Diabetes Mellitus
Major Benefits of New Wosulin 30/70 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of New Wosulin 30/70 Injection:
- Hypoglycemia (low blood glucose level)
- Injection site reactions (pain, swelling, redness)
- Weight gain
How to use New Wosulin 30/70 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How New Wosulin 30/70 Injection works:
Isophane insulin provides sustained glucose management, whereas regular human insulin offers rapid action. Their combined effect achieves consistent blood sugar control through enhanced glucose uptake in muscle and adipose tissue, and reduced hepatic glucose output.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using New Wosulin 30/70 Injection is inadvisable.
PregnancySAFE IF PRESCRIBED
The safety profile of Wosulin 30/70 Injection during pregnancy is generally favorable. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactating individuals can safely use the new Wosulin 30/70 Injection. Research in humans indicates minimal transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using New Wosulin 30/70 Injection. Dosage modification of New Wosulin 30/70 Injection may be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide appropriate dosage.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using New Wosulin 30/70 Injection. Dosage modification of New Wosulin 30/70 Injection might be necessary. Physician consultation is advised. Routine blood glucose monitoring is suggested to guide dosage changes.
What if you forget to take New Wosulin 30/70 Injection :
Omitting a scheduled dose of New Wosulin 30/70 Injection can lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar levels and adjust your subsequent injection accordingly.
Facts to Know About New Wosulin 30/70 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently